The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000895381
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
14/05/2026
Date registered
Help: Date registered
20/07/2026
Date last updated
Help: Date last updated
20/07/2026
Date data sharing statement initially provided
Help: Data sharing statement date
20/07/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Effectiveness of immersive virtual reality in enhancing verbal de-escalation skills of emergency department staff: a mixed methods study
Scientific title
Effectiveness of immersive virtual reality (IVADE) in enhancing verbal de-escalation skills of emergency department staff: a mixed methods study
Additional trial identifiers [1] 317276 0
IVADE
Universal Trial Number (UTN)
Trial acronym
IVADE (Immersive Virtual Reality De-Escalation Skills Trial)
Related trial records

Health condition
Health condition(s) studied:
Behaviours of concern 341903 0
Occupational violence 341904 0
Condition category
Condition code
Emergency medicine 337963 337963 0 0
Other emergency care
Public Health 338441 338441 0 0
Health service research
Mental Health 338442 338442 0 0
Other mental health disorders

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
IVADE is a virtual reality (VR) training package co-designed with clinicians and health system stakeholders for verbal de-escalation training specific to the Australian health context, including nursing students. With IVADE, participants will complete virtual tutoring to familiarise themselves with the VR system and controllers, including information on de-escalation techniques. Participants consolidate all their de-escalation training (e-learning and face-to-face) by applying them in these IVADE scenarios once a week until completion:

1. Aggressive patient due to long wait time; can turn violent (de-escalation possible)
2. Alcohol-fuelled aggression; can turn violent (de-escalation possible)
3. Alcohol-fuelled aggression; will turn violent (de-escalation not possible)
4. Elderly dementia patient; can turn violent (de-escalation possible)
5. Mental health patient; can turn violent (de-escalation possible)
6. Adolescent patient; can turn violent (de-escalation possible)

IVADE scenarios involve interactions between the participant and a patient, with user-choices determining potential different outcomes for each scenario. As an example, a scenario may have up to 38 decision options leading to six different potential outcomes, including the ability to call for security at any time. Each participant will spend about 15 minutes per scenario where they can choose different options and explore alternative scenario outcomes.

Each research site will have an educator or facilitator to administer IVADE. It is expected that IVADE training sessions are held in a room that should be safe for a learner to participate in IVADE training. These are adequately sized rooms with good ventilation and lighting, equipped with computer workstation, a clear open area for the learner to move during scenarios, and seating.

Each site educator or facilitator will keep a logbook of participant IDs that will record date, time in, time out, side-effects such as dizziness, headaches, nausea, and incidents (e.g. trips, falls). The incident rate should be low based on prior studies that showed that 1 in 10 experienced mild motion sickness and no trips and falls reported
Intervention code [1] 334052 0
Prevention
Intervention code [2] 334354 0
Treatment: Devices
Intervention code [3] 334355 0
Behaviour
Description of the comparator or control
The control group will be ED staff who receive base training that includes Maybo and Safety Essentials in the Emergency Department training. In other words, base training is an institutional training requirement. The mandatory e-learning (Maybo) is self-paced, and participants would have completed this within 30 days of employment and renewed every 2-3 years.

Face-to-face modules (extension of the e-learning and Safety Essentials in the Emergency Department) covers all de-escalation components: 1) Valuing the person; 2) Reducing the person’s fear; 3) Inquiring about the person’s concerns and anxiety; 4) Providing guidance to the person, such as options and solutions; 5) Working out possible agreements, such as safer options and acceptable behaviours; 6) Maintaining a calm demeanour; 7) Maintaining a safe distance from the person. Face-to-face modules are delivered in a group setting.
Control group
Active

Outcomes
Primary outcome [1] 345396 0
Confidence measured by Coping with Patient Aggression Instrument (CCPAI)
Timepoint [1] 345396 0
Baseline (M1, before IVADE training); three months (M2); six months (M3); 12 months after training (M4).
Secondary outcome [1] 461520 0
Attitudes as measured by Management of Aggression and Violence Attitudes Scale (MAVAS)
Timepoint [1] 461520 0
Baseline (M1, before IVADE training); three months (M2); six months (M3); 12 months after training (M4).

Eligibility
Key inclusion criteria
Are a registered health practitioner (e.g. nurses, doctors, allied health personnel) in Australia by the Australian Health Practitioner Regulation Agency;

Completed their occupational violence (OV) e-learning in the last 12 months;

Have completed any in-house face-to-face education or training for OV in the last 6 months;

Work permanent part-time, full-time or >12-month contract in participating emergency departments (ED);

AND

If they do not suffer from severe motion sickness, vertigo, or any other stated contraindication by the person.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
Yes
Key exclusion criteria
Are NOT a registered health practitioner in Australia;

Have NOT completed their OV e-learning in the last 12 months;

Have NOT completed any in-house face-to-face education or training for OV in the last 6 months;

Work on a casual or contractual basis (less than 12 months) in a participating study ED; OR

If they suffer from severe motion sickness, vertigo, or any other stated contraindication by the person.

Study design
Purpose of the study
Educational / counselling / training
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Participants will be randomised in a 1:1 ratio via online web randomizer
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
web-based randomiser - Research Randomizer
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
Demographic information will be summarised as proportions and percentages; and differences between the IVADE and Control Groups will be explored using Chi-square test. Primary study outcome, CCPAI, will be summed wherein higher scores are interpreted as higher confidence among participants. Between group differences at every time point (Baseline, 3, 6, and 12 months) will be explored using t-test. Within group changes of CCPAI over time will be explored using repeated measures analysis of variance. Between-group and within-group improvements in CCPAI scores with a corresponding p value of <0.05 will be considered statistically significant. If data do not meet the assumption of normal distribution, equivalent non-parametric tests will be used. MAVAS scores will be treated as ordinal data. Between-group, and within-group differences will be evaluated by comparing median values for each of the 23 statements using a non-parametric test (Mann–Whitney U test), to enable benchmarking with existing studies. Statistical analysis will be conducted using SPSS Statistics Version 29.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD
Recruitment hospital [1] 29525 0
Princess Alexandra Hospital - Woolloongabba
Recruitment hospital [2] 29526 0
Queen Elizabeth II Jubilee Hospital - Coopers Plains
Recruitment hospital [3] 29527 0
Beaudesert Hospital - Beaudesert
Recruitment postcode(s) [1] 45843 0
4102 - Woolloongabba
Recruitment postcode(s) [2] 45844 0
4108 - Coopers Plains
Recruitment postcode(s) [3] 45845 0
4285 - Beaudesert

Funding & Sponsors
Funding source category [1] 321851 0
Charities/Societies/Foundations
Name [1] 321851 0
Emergency Medicine Foundation
Country [1] 321851 0
Australia
Primary sponsor type
Charities/Societies/Foundations
Name
Emergency Medicine Foundation
Address
Country
Australia
Secondary sponsor category [1] 324729 0
Commercial sector/Industry
Name [1] 324729 0
AlphaImmersion
Address [1] 324729 0
Country [1] 324729 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320390 0
Metro South Human Research Ethics Committee
Ethics committee address [1] 320390 0
Ethics committee country [1] 320390 0
Australia
Date submitted for ethics approval [1] 320390 0
13/03/2026
Approval date [1] 320390 0
22/04/2026
Ethics approval number [1] 320390 0
HREC/QMS/127227

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 150322 0
Dr CJ Cabilan
Address 150322 0
Princess Alexandra Hospital Emergency Department, 199 Ipswich Rd, Woolloongabba, 4102 QLD
Country 150322 0
Australia
Phone 150322 0
+61 7 3176 7533
Fax 150322 0
Email 150322 0
Contact person for public queries
Name 150323 0
CJ Cabilan
Address 150323 0
Princess Alexandra Hospital Emergency Department, 199 Ipswich Rd, Woolloongabba, 4102 QLD
Country 150323 0
Australia
Phone 150323 0
+61 7 3176 7533
Fax 150323 0
Email 150323 0
Contact person for scientific queries
Name 150324 0
CJ Cabilan
Address 150324 0
Princess Alexandra Hospital Emergency Department, 199 Ipswich Rd, Woolloongabba, 4102 QLD
Country 150324 0
Australia
Phone 150324 0
+61 7 3176 7533
Fax 150324 0
Email 150324 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.